The ENPP1 expression in adipose tissue is increased in obese patients with insulin resistance [35], and ENPP1 is also considered both a biomarker and a novel potential therapeutic target to improve adipose tissue function and systemic glucose metabolism. Here, ENPP1 is linked to Insulin resistance.